Actavis recalls diabetes drugs made by Durham-based Patheon

Actavis, the generic drug unit that Allergan (NYSE: AGN) recently sold to Teva Pharmaceutical Industries (NYSE: TEVA), has recalled five lots of a diabetes drug that were manufactured under a contract by Durham-based Patheon (NYSE: PTHN). According to Patheon, a problem with the diabetes drug Glipizide arose after the size of the pill bottle was increased, and a drying agent was included in the new bottle. “The issue was not related to the manufacturing or packaging services provided by Patheon,”…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news